Analyst Insights and Signify Premium Insights

Medical imaging AI is increasingly included within radiology IT tenders, with imaging IT vendors needing to address how the integration of AI image analysis tools into the workflow will be achieved.

ECR 2024 illuminated the horizon of medical imaging, unveiling a seamless fusion of product breakthroughs and refined techniques that herald a new era in radiology. The overarching theme of this year's European Congress of Radiology encapsulated the dynamic evolution of the medical imaging landscape to capture the latest pioneering advancements.

We have prepared an infographic that demonstrates the developing vendor ecosystem how AI is currently used in the ultrasound pathway.

In the last 18 months, there have been several developments in the ultrasound AI market. New solutions have been commercially approved, reimbursement codes have been awarded and ultrasound OEMs and AI vendors are working closer together.

Find out what the biggest AI in medical imaging trends were at ECR 2024, and what was new at this year’s congress in this insight written by Ellie Baker.

The medical FPD market, totalling just under 78,000 units in 2022, witnessed a slight retraction in both units and revenue. The most significant decline was seen in mobile general radiography, which was attributed to a surplus during the pandemic. A decline was also seen for mammography due to a shortage of semi-conductors, inflation hikes, and a market correction following elevated investment in breast imaging systems in 2021 as budgets returned post-COVID. However, the resurgence of elective procedures, coupled with pent-up demand, contributed to the positive uptake of mobile C-arm technology.

The digital health market was inundated with several announcements off the back of the ViVE 2024 conference last month. As it pertains to high-acuity telehealth, many announcements over the last year have related to the growing uptake of virtual nursing and virtual sitting technologies, along with the introduction of Gen-AI capabilities within telehealth applications.

The Hospital-at-Home market has received much attention in the wake of the COVID-19 Pandemic as a means to alleviate hospital bed shortages, reduce costs, and improve health outcomes for appropriate patients. Advances in remote patient monitoring technologies and a supportive policy environment offer much promise, but formidable obstacles remain.

Signify Research’s Generative AI Market Intelligence Service delivers thorough analysis and a reliable product database, empowering decision-makers with insights into use cases and competitive vendors within the realm of generative AI capabilities in medical imaging.

The Infusion market has seen various swings in competitive dynamics in recent years. Product recalls, company acquisitions, new product launches, component supply issues and the uptick in demand seen following the COVID-19 pandemic have all had their impact on the market environment. This insight provides a deeper dive into the evolution of the infusion market and subsequent impact on share of the leading players.

The market potential for the ultrasound digital ecosystem is substantial, a multi-billion market opportunity.

Momentum has been incrementally building towards initial customer education and the nascent establishment of the market for monetizing imaging data. While this is a concept that is by no means unexplored across healthcare and life sciences, proliferation has been confined primarily to patient registries, electronic health records and insurance databases so far.